Citations

Citations to this article as recorded by  

• Association of metabolic dysfunction-associated steatotic liver disease trajectories with incident liver cancer: a UK Biobank cohort study
  Ryuk Jun Kwon, Yohwan Lim
  Frontiers in Endocrinology.2026;[Epub]     CrossRef
• Association of Lifestyle Behaviors and Cancer Risk in MetALD
  Ryuk Jun Kwon, Yohwan Lim
  Cancers.2026; 18(16): 2563.     CrossRef
• Joint associations of cardiovascular polygenic risk and a health-related risk profile with incident cardiovascular disease among adults with depression: a UK Biobank study
  Yohwan Lim, Ryuk Jun Kwon
  Frontiers in Endocrinology.2026;[Epub]     CrossRef
• BMI-Based and Clinical-Obesity Trajectories and Incident Cardiovascular Disease: A Prospective UK Biobank Study
  Ryuk Jun Kwon, Yohwan Lim
  Journal of Clinical Medicine.2026; 15(17): 6530.     CrossRef
• Metabolic dysfunction-associated steatotic liver disease, metabolic alcohol-related liver disease, and incident dementia: a nationwide cohort study
  Woo-Young Shin, Eun Seok Kang, Yun Hwan Oh, Meng Sha, Qiang Xia, Seogsong Jeong, Yoosun Cho
  BMC Gastroenterology.2025;[Epub]     CrossRef
• Identification of potentially effective drugs for metabolic dysfunction-associated steatotic liver disease against liver cirrhosis: In-silico drug repositioning-based retrospective cohort study
  Chae Won Lee, Eun Seok Kang, Seogsong Jeong, Hyun Wook Han, Samuel O. Antwi
  PLOS One.2025; 20(6): e0323880.     CrossRef